0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Continuous Subcutaneous Insulin Infusion Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-24Q7857
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global and Japan Continuous Subcutaneous Insulin Infusion Devices Market Insights Forecast to 2027
BUY CHAPTERS

Continuous Subcutaneous Insulin Infusion Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24Q7857
Report
October 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Continuous Subcutaneous Insulin Infusion Devices - Market Size

The global market for Continuous Subcutaneous Insulin Infusion Devices was estimated to be worth US$ 4254 million in 2023 and is forecast to a readjusted size of US$ 6119.6 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Continuous Subcutaneous Insulin Infusion Devices - Market

Continuous Subcutaneous Insulin Infusion Devices - Market

Continuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitus
The Insulin Pen and Pump market is primarily driven by the increasing prevalence of diabetes and the need for convenient and accurate insulin delivery methods. Insulin pens and pumps offer user-friendly options for individuals with diabetes to manage their blood sugar levels effectively. The growing awareness of diabetes management, coupled with the advantages of improved dosing accuracy, reduced needle injections, and better glycemic control, contributes to market growth. Moreover, the trend towards personalized medicine and the demand for discreet and easy-to-use devices further propel adoption. However, challenges include patient adherence to treatment regimens, addressing potential technical issues with pumps, and ensuring proper insulin storage for pens. Navigating the competitive landscape and providing education on proper device usage are ongoing concerns. The market's success relies on continuous innovation to enhance device features, comprehensive patient education on insulin management, and collaborations between medical device manufacturers and healthcare professionals to offer reliable, user-centric, and effective insulin pen and pump solutions while addressing the evolving challenges associated with diabetes management.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Continuous Subcutaneous Insulin Infusion Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Continuous Subcutaneous Insulin Infusion Devices by region & country, by Type, and by Application.
The Continuous Subcutaneous Insulin Infusion Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Subcutaneous Insulin Infusion Devices.
Market Segmentation

Scope of Continuous Subcutaneous Insulin Infusion Devices - Market Report

Report Metric Details
Report Name Continuous Subcutaneous Insulin Infusion Devices - Market
Forecasted market size in 2030 US$ 6119.6 million
CAGR 5.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL, Microport
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Continuous Subcutaneous Insulin Infusion Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Continuous Subcutaneous Insulin Infusion Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Continuous Subcutaneous Insulin Infusion Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Continuous Subcutaneous Insulin Infusion Devices - Market size in 2030?

Ans: The Continuous Subcutaneous Insulin Infusion Devices - Market size in 2030 will be US$ 6119.6 million.

Who are the main players in the Continuous Subcutaneous Insulin Infusion Devices - Market report?

Ans: The main players in the Continuous Subcutaneous Insulin Infusion Devices - Market are Medtronic, Roche, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL, Microport

What are the Application segmentation covered in the Continuous Subcutaneous Insulin Infusion Devices - Market report?

Ans: The Applications covered in the Continuous Subcutaneous Insulin Infusion Devices - Market report are Type I Diabetes, Type II Diabetes

What are the Type segmentation covered in the Continuous Subcutaneous Insulin Infusion Devices - Market report?

Ans: The Types covered in the Continuous Subcutaneous Insulin Infusion Devices - Market report are Normal Pump, Patch Pump

Recommended Reports

Insulin Delivery Devices

Glucose Monitoring Systems

Insulin Pens and Wearables

1 Market Overview
1.1 Continuous Subcutaneous Insulin Infusion Devices Product Introduction
1.2 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Forecast
1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030)
1.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume (2019-2030)
1.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Price (2019-2030)
1.3 Continuous Subcutaneous Insulin Infusion Devices Market Trends & Drivers
1.3.1 Continuous Subcutaneous Insulin Infusion Devices Industry Trends
1.3.2 Continuous Subcutaneous Insulin Infusion Devices Market Drivers & Opportunity
1.3.3 Continuous Subcutaneous Insulin Infusion Devices Market Challenges
1.3.4 Continuous Subcutaneous Insulin Infusion Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Continuous Subcutaneous Insulin Infusion Devices Players Revenue Ranking (2023)
2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2019-2024)
2.3 Global Continuous Subcutaneous Insulin Infusion Devices Players Sales Volume Ranking (2023)
2.4 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Company Players (2019-2024)
2.5 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Continuous Subcutaneous Insulin Infusion Devices
2.9 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Analysis
2.9.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Continuous Subcutaneous Insulin Infusion Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Normal Pump
3.1.2 Patch Pump
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type
3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value, by Type (2019-2030)
3.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Type
3.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Type I Diabetes
4.1.2 Type II Diabetes
4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application
4.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value, by Application (2019-2030)
4.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Application
4.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region
5.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (2019-2024)
5.1.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (2025-2030)
5.1.4 Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (%), (2019-2030)
5.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region
5.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (2019-2024)
5.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (2025-2030)
5.2.4 Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
5.4.2 North America Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
5.5.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
5.7.2 South America Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value
6.2.1 Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.3.2 United States Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.4.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.5.2 China Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.6.2 Japan Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.7.2 South Korea Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019-2030
6.9.2 India Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.1.5 Medtronic Recent Development
7.2 Roche
7.2.1 Roche Company Information
7.2.2 Roche Introduction and Business Overview
7.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Roche Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.2.5 Roche Recent Development
7.3 Insulet Corp
7.3.1 Insulet Corp Company Information
7.3.2 Insulet Corp Introduction and Business Overview
7.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.3.5 Insulet Corp Recent Development
7.4 Tandem Diabetes care
7.4.1 Tandem Diabetes care Company Information
7.4.2 Tandem Diabetes care Introduction and Business Overview
7.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.4.5 Tandem Diabetes care Recent Development
7.5 Valeritas
7.5.1 Valeritas Company Information
7.5.2 Valeritas Introduction and Business Overview
7.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.5.5 Valeritas Recent Development
7.6 SOOIL
7.6.1 SOOIL Company Information
7.6.2 SOOIL Introduction and Business Overview
7.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.6.5 SOOIL Recent Development
7.7 Microport
7.7.1 Microport Company Information
7.7.2 Microport Introduction and Business Overview
7.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Microport Continuous Subcutaneous Insulin Infusion Devices Product Offerings
7.7.5 Microport Recent Development
8 Industry Chain Analysis
8.1 Continuous Subcutaneous Insulin Infusion Devices Industrial Chain
8.2 Continuous Subcutaneous Insulin Infusion Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Continuous Subcutaneous Insulin Infusion Devices Sales Model
8.5.2 Sales Channel
8.5.3 Continuous Subcutaneous Insulin Infusion Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Continuous Subcutaneous Insulin Infusion Devices Market Trends
    Table 2. Continuous Subcutaneous Insulin Infusion Devices Market Drivers & Opportunity
    Table 3. Continuous Subcutaneous Insulin Infusion Devices Market Challenges
    Table 4. Continuous Subcutaneous Insulin Infusion Devices Market Restraints
    Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Company (2019-2024)
    Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Continuous Subcutaneous Insulin Infusion Devices Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Continuous Subcutaneous Insulin Infusion Devices
    Table 13. Global Continuous Subcutaneous Insulin Infusion Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Devices as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (2019-2024) & (%)
    Table 44. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Region (2025-2030) & (%)
    Table 45. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Volume, (2025-2030) & (K Units)
    Table 57. Medtronic Company Information
    Table 58. Medtronic Introduction and Business Overview
    Table 59. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 61. Medtronic Recent Development
    Table 62. Roche Company Information
    Table 63. Roche Introduction and Business Overview
    Table 64. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Roche Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 66. Roche Recent Development
    Table 67. Insulet Corp Company Information
    Table 68. Insulet Corp Introduction and Business Overview
    Table 69. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 71. Insulet Corp Recent Development
    Table 72. Tandem Diabetes care Company Information
    Table 73. Tandem Diabetes care Introduction and Business Overview
    Table 74. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 76. Tandem Diabetes care Recent Development
    Table 77. Valeritas Company Information
    Table 78. Valeritas Introduction and Business Overview
    Table 79. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 81. Valeritas Recent Development
    Table 82. SOOIL Company Information
    Table 83. SOOIL Introduction and Business Overview
    Table 84. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 86. SOOIL Recent Development
    Table 87. Microport Company Information
    Table 88. Microport Introduction and Business Overview
    Table 89. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Microport Continuous Subcutaneous Insulin Infusion Devices Product Offerings
    Table 91. Microport Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Continuous Subcutaneous Insulin Infusion Devices Downstream Customers
    Table 95. Continuous Subcutaneous Insulin Infusion Devices Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Continuous Subcutaneous Insulin Infusion Devices Product Picture
    Figure 2. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered
    Figure 7. Global Continuous Subcutaneous Insulin Infusion Devices Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Continuous Subcutaneous Insulin Infusion Devices Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Continuous Subcutaneous Insulin Infusion Devices Revenue in 2023
    Figure 10. Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Normal Pump Picture
    Figure 12. Patch Pump Picture
    Figure 13. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Type I Diabetes
    Figure 19. Product Picture of Type II Diabetes
    Figure 20. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Continuous Subcutaneous Insulin Infusion Devices Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Continuous Subcutaneous Insulin Infusion Devices Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Continuous Subcutaneous Insulin Infusion Devices Sales Volume (%), (2019-2030)
    Figure 37. United States Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Continuous Subcutaneous Insulin Infusion Devices Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Continuous Subcutaneous Insulin Infusion Devices Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Continuous Subcutaneous Insulin Infusion Devices Sales Value by Application (%), 2023 VS 2030
    Figure 58. Continuous Subcutaneous Insulin Infusion Devices Industrial Chain
    Figure 59. Continuous Subcutaneous Insulin Infusion Devices Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS